INS and cancer: Weinstein et al. studied the comparative mitogenic effect at supraphysiologic doses of regular insulin and insulin analogues glargine, detemir, lispro, and aspart to IGF-1 in cancer-derived cell lines from colon (HCT116), prostate (PC3), and breast (MCF-7) [95].